FACE TO FACE: Dr Taslimarif Saiyed, Director and CEO, Centre for Cellular and Molecular Platforms (C-CAMP)

Taslimarif Saiyed, Director and CEO, Centre for Cellular and Molecular Platforms (C-CAMP) talks about the relevance of Startup Mahakumbh event, key factors driving startup ecosystem, latest trends, challenges and much more.

0
82
In an exclusive interview, Rahul Koul, Chief Editor, BioVoice News spoke to Taslimarif Saiyed, Director and CEO, Centre for Cellular and Molecular Platforms (C-CAMP) on the relevance of Startup Mahakumbh event, key factors driving startup ecosystem, challenges and much more.

Key talk points:
♦ Startup Mahakumbh, world’s largest startup event is happening from 3rd to 5th April 2025 in New Delhi. As the head of the Biotech/HealthTech Pavilion at Startup Mahakumbh, please walk us through some of the key highlights?
♦ How do you see the biotech and HealthTech startup ecosystem evolving in India, and how can events like Startup Mahakumbh help accelerate this growth?
♦ What are the biggest challenges faced by bioscience entrepreneurs in India and how can we address these issues?
♦ C-CAMP plays a crucial role in supporting startups and innovators. How does C-CAMP address the challenges of scaling up new technologies from research to real-world applications, particularly in terms of funding and infrastructure?
♦ Looking ahead, what are your long-term goals for C-CAMP? How do you envision the center evolving in the next 5–10 years?
♦ How do you see emerging technologies like artificial intelligence, CRISPR, and genomics transforming healthcare, especially in developing countries like India?
♦ Finally, what advice would you give to biotech entrepreneurs and innovators looking to scale their startups in India’s competitive market?


About Dr Taslimarif Saiyed: Dr Taslimarif Saiyed received his PhD from Max-Planck Institute for Brain Research, Germany and followed it up by postdoctoral training at University of California San Francisco (UCSF). At the same time, he also underwent training in management for Biotech and Innovation from QB3 at UC Santa Cruz, UC Berkeley and UC San Francisco. He has also completed a biotech management program for biotech executives at Wharton School of Management.
Dr Saiyed is an Adjunct Faculty at Indian Institute of Technology (IIT) Madras and also Amrita Institute – School of Biotechnology. He also heads the Discovery to Innovation Accelerator program at C-CAMP. He is actively involved in promoting innovation in lifescience / healthcare by supporting translation of discoveries to application, entrepreneurship and technology development.

Click to read the detailed interview